Skip to content

Clinical Study to Evaluate the Short Time Efficacy of AP Green Tea Extract Affer High Fat, High Carbohydrate Diet

A Randomized, Cross-Over Clinical Study to Evaluate the Acute Efficacy of AP Green Tea Extract After a Meal Composed of High-Fat/High-Carbohydrate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04850326
Enrollment
20
Registered
2021-04-20
Start date
2020-07-24
Completion date
2021-02-26
Last updated
2021-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose, High

Brief summary

The objective of this clinical trial is to evaluate the short term effects of single dose AP green tea extracts in subjects with BMI (\< 30 kg/m2) and fasting glucose level of \> 100 mg/dL after high-fat/high-carbohydrate meal.

Interventions

DIETARY_SUPPLEMENTAP green tea extract

single intake of AP green tea extract

Sponsors

Amorepacific Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects aged 19 years or over * BMI \< 30 kg/m2 * Fasting glucose level \> 100 mg/dL (who is not under medication) * Subjects who voluntarily decide to participate in this clinical study and sign the informed consent form on their own or through their representatives

Exclusion criteria

* At the screening visit, subjects who were diagnosed with obesity, diabetes, dyslipidemia and undergoing medication * Subjects who were diagnosed with ventricular associated disease, unstable and uncontrolled chronic medical disease, hyper/hypothyroidism, or active malignant tumor and undergoing medication within 4 weeks prior to the first administration of the investigational product * Subjects who have renal failure, acute or chronic hepatitis or known liver cirrhosis * In addition to the above, subjects who are determined to be ineligible to participate in the clinical study according to the investigator's medical opinion

Design outcomes

Primary

MeasureTime frameDescription
Change of Blood glucose level0 - 300 minuteChange of Blood glucose level before and after high-carbohydrate/high-fat meal
Change of Insulin level0 - 300 minuteChange of Insulin level before and after high-carbohydrate/high-fat meal
Change of Triglyceride level0 - 300 minuteChange of Triglyceride level before and after high-carbohydrate/high-fat meal

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026